National leaders in stem cell transplant and cellular therapy
When it comes to diagnosing and treating patients with complex cancers like leukemia, lymphoma, multiple myeloma or metastatic germ cell tumors like testicular cancer, you have access to the multidisciplinary team at Indiana University Health Medical Center, a partner to the only NCI-designated comprehensive cancer center in Indiana.
At IU Health Medical Center, your patients can access leading-edge cellular therapy. Our care team is shaping the future of cancer treatment with more than 30 years of clinical breakthroughs in these types of cancer. IU Health Medical Center continues to be nationally recognized by U.S. News & World Report Best Hospital rankings, and our cancer program is rated high performing in 2025.
In partnership with the IU Melvin and Bren Simon Comprehensive Cancer Center, we offer access to the latest therapies available across autologous stem cell transplant, CAR -T cell therapy, and allogeneic stem cell transplant; including full match, half-match and mismatched donors, greatly expanding the available donor pool and making more patients eligible for transplants.
Our research and clinical teams are on the forefront of advancing the role of cellular therapy in the treatment of patients with cancer, moving bench side research to bedside care. Through our collaboration with the Brown Center for Immunotherapy, our research pipeline includes:
IU Health Medical Center, in partnership with the IU Simon Comprehensive Cancer Center, is a member of the National Comprehensive Cancer Network (NCCN), a network of 33 leading cancer centers devoted to patient care, research and education. We are members of the national guidelines committees, setting the treatment standards for the nation.
Our program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). Our program exceeds standards in patient care and laboratory practices for cellular therapy, offering your patients the highest quality of care and outcomes.
IU Health Medical Center is an affiliate site of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) contributing to multi-institutional clinical trials addressing important issues in stem cell transplantation, thereby furthering understanding of the best possible treatment approaches.
Our program offers a team of dedicated transplant physicians with expertise across leukemia, myeloproliferative disorders, myelodysplastic syndromes, lymphoma, multiple myeloma and metastatic germ cell tumors.
Our program is Indiana’s largest transplant program, completing approximately 300 transplants annually.
IU Health Medical Center is routinely recognized by U.S. News & World Report Best Hospital rankings and our Cancer program is rated high performing in 2025.
IU Health Medical Center has a history of more than 30 years in clinical breakthroughs in complex blood and bone marrow cancers. Our program has:
From the moment a patient is referred, our nurse coordinators will help guide them through every step until treatment and then in the post transplantation setting. Our multidisciplinary care team includes highly skilled clinical nurses, pharmacists, dieticians and social workers; all with unique expertise in bone marrow transplant and cellular therapy. For patients with additional care needs, our program offers access to clinical specialists with decades of experience caring for patients undergoing stem cell transplant or cellular therapy. Our team members are dedicated to communication and follow up between referring providers and IU Health.
At IU Health Medical Center, your patients can access leading-edge cellular therapy. Our care team is shaping the future of cancer treatment with more than 30 years of clinical breakthroughs in these types of cancer. IU Health Medical Center continues to be nationally recognized by U.S. News & World Report Best Hospital rankings, and our cancer program is rated high performing in 2025.
In partnership with the IU Melvin and Bren Simon Comprehensive Cancer Center, we offer access to the latest therapies available across autologous stem cell transplant, CAR -T cell therapy, and allogeneic stem cell transplant; including full match, half-match and mismatched donors, greatly expanding the available donor pool and making more patients eligible for transplants.
Our research and clinical teams are on the forefront of advancing the role of cellular therapy in the treatment of patients with cancer, moving bench side research to bedside care. Through our collaboration with the Brown Center for Immunotherapy, our research pipeline includes:
IU Health Medical Center, in partnership with the IU Simon Comprehensive Cancer Center, is a member of the National Comprehensive Cancer Network (NCCN), a network of 33 leading cancer centers devoted to patient care, research and education. We are members of the national guidelines committees, setting the treatment standards for the nation.
Our program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). Our program exceeds standards in patient care and laboratory practices for cellular therapy, offering your patients the highest quality of care and outcomes.
IU Health Medical Center is an affiliate site of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) contributing to multi-institutional clinical trials addressing important issues in stem cell transplantation, thereby furthering understanding of the best possible treatment approaches.
Our program offers a team of dedicated transplant physicians with expertise across leukemia, myeloproliferative disorders, myelodysplastic syndromes, lymphoma, multiple myeloma and metastatic germ cell tumors.
Our program is Indiana’s largest transplant program, completing approximately 300 transplants annually.
IU Health Medical Center is routinely recognized by U.S. News & World Report Best Hospital rankings and our Cancer program is rated high performing in 2025.
IU Health Medical Center has a history of more than 30 years in clinical breakthroughs in complex blood and bone marrow cancers. Our program has:
From the moment a patient is referred, our nurse coordinators will help guide them through every step until treatment and then in the post transplantation setting. Our multidisciplinary care team includes highly skilled clinical nurses, pharmacists, dieticians and social workers; all with unique expertise in bone marrow transplant and cellular therapy. For patients with additional care needs, our program offers access to clinical specialists with decades of experience caring for patients undergoing stem cell transplant or cellular therapy. Our team members are dedicated to communication and follow up between referring providers and IU Health.
Watch as Dr. Nabil Adra explains how IU Health cares for your patients with testicular cancer and metastatic germ cell tumors. "Our overall goal at IU Health is to offer the best advances for patients with testicular cancer."
Jennifer Schwartz serves as Interim Director of Stem Cell Transplant and Cellular Therapy at IU Health. She is the Associate Dean of Continuing Education in Healthcare Professions at the IU School of Medicine. Connect with Dr. Schwartz on Doximity.
Varun Mittal is an Assistant Professor of Clinical Medicine and Bone Marrow Transplant specialist. Connect with Dr. Mittal on Doximity.
Zachary Meyer is an Assistant Professor of Clinical Medicine and Bone Marrow Transplant specialist. Connect with Dr. Meyer on Doximity.
Huda Salman is the Executive Director of the Brown Center for Immunotherapy as well as the Don Brown Professor of Immunotherapy at the IU School of Medicine. She serves as the program leader for Leukemia. Connect with Dr. Salman on Doximity.
Chaiyaporn Boonchalermvichian, MD, PhD is an Assistant Professor of Clinical Medicine and Bone Marrow Transplant Specialist. Connect with Dr. Boonchalermvichian on Doximity.
Zainul Hasanali, MD is the Daniel and Lori Efroymson Scholar in Oncology and Assistant Professor of Medicine with IU School of Medicine. He is a Bone Marrow Transplant specialist with IU Health. Connect with Dr. Hasanali on Doximity.